Sexually-dimorphic effects of L2-Cmu on inflammatory markers A rise in pro-inflammatory mediators is a hallmark of aging, thus we evaluated plasma inflammatory markers using a 25-plex immunoassay to determine if these parameters were affected by mAb treatment in male and female mice
Multiple clinical trials confirm this with consistent results
By combining expert clinical oversight with a flexible, personalized approach, we help you achieve sustainable results while maintaining the freedom to live your life
Beyond diabetes management, certain GLP-1 receptor agonist medications have demonstrated cardiovascular benefits in clinical trials, though these benefits shouldn't be attributed to endogenous GLP-1 function alone
Referencias Emma Simonsen MD , Lars Christian Lund PhD , Martin Thomsen Ernst MSc , Vidar Hjellvik PhD , Laszlo Hegeds DMSc , Steffen Hamann PhD , ystein Kalsnes Jrstad PhD , et al